FDA clearance for Brainlab's radiosurgery software
This article was originally published in Clinica
Executive Summary
The HybridArc radiosurgery planning software developed by Brainlab has gained 510(k) clearance from the US FDA. The software is designed to increase the efficiency of existing Linac (linear accelerator) technology, to allow fast, high precision volumetric arc radiosurgery treatment without requiring hardware upgrades. HybridArc uses an adaptive dose calculation matrix and can typically calculate stereotactic cranial and spinal radiosurgery plans within a few minutes. It also spares nearby organs and causes lower residual dose compared with other techniques such as rotational intensity modulated radiotherapy, Munich, Germany-based Brainlab says. HybridArc is now approved for use in Europe and the US.